To explore the impact of dasatinib dose on PASP during therapy, PSM analysis was performed and the covariates were matched for sex, age, time from diagnosis to initiation of dasatinib therapy, dasatinib line used in TKI therapy, BSA, and cardiopulmonary diseases (Table 6). The gene discussed is CPB1; the disease is cor pulmonale.